数据集的SARS-CoV-2尖端蛋白受体结合域变异复杂与抗原结合片段针对COVID-19疫苗参考变异
Ferdinando Spagnolo1,2,3, Florigio Lista2, Claudia Curcio3
1School of Advanced Defence Studies, Defence Research and Analysis Institute, Piazza della Rovere 83 Rome, Italy.
Data in brief
|February 5, 2025
概括
本研究介绍了SARS-CoV-2尖端蛋白受体结合域 (RBD) 变体的同质模型,其中包括新疫苗相关的KP.2变体. 该数据集有助于理解抗体对抗不断演变的病毒菌株的有效性.
科学领域:
- 结构生物学 结构生物学
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- SARS-CoV-2尖端蛋白受体结合域 (RBD) 进化需要了解抗体相互作用.
- 现有的结构数据可能不涵盖所有新出现的变异,限制了疫苗和治疗开发.
- 在最近的疫苗更新中包含KP.2变种强调了更新结构信息的必要性.
研究的目的:
- 为生成与抗原结合片段 (Fabs) 复杂的SARS-CoV-2 RBD变体的同质模型结构的综合数据集.
- 为分析抗体-抗原相互作用和疫苗疗效提供高质量的结构数据.
- 将KP.2变种纳入当前COVID-19疫苗策略的相关性.
主要方法:
- 14个SARS-CoV-2 RBD变体的同质模型复杂化与Fabs来自PDB结构8GPY,8H7Z和8XE9.9.
- 使用施罗丁格生物发光剂和能源最小化进行精炼.
- 使用Prime MM-GBSA与VSGB溶解和OPLS4力场计算结合亲缘关系.
主要成果:
- 为14个RBD变体和3个Fab对生成了6组复杂结构的数据集.
- 计算了结合 afinities,使抗原-抗体相互作用的排名.
- 数据集包括野生类型,BETA,XBB.1.5和KP.2.5等变体的模型.
结论:
- 生成的数据集为各种SARS-CoV-2变体的抗体结合提供了有价值的结构性见解.
- 这个资源可以支持对病毒免疫逃避和疫苗有效性的深入研究.
- 将KP.2变种纳入其中,增强了数据集对于正在进行的公共卫生工作的直接相关性.
相关概念视频
Cross-reactivity
30.9K
Overview
30.9K
Conjugated Proteins
18.2K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.2K
Single Nucleotide Polymorphisms-SNPs
13.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.9K


